Zhixiang He

Affiliations: 
2013-2016 School of Life Sciences, Xiamen University 
Google:
"Zhixiang He"
Mean distance: (not calculated yet)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Gui F, Jiang B, Jiang J, et al. (2024) Acute BRCAness Induction and AR Signaling Blockage through CDK12/7/9 Degradation Enhances PARP Inhibitor Sensitivity in Prostate Cancer. Biorxiv : the Preprint Server For Biology
Ji W, Du G, Jiang J, et al. (2024) Discovery of bivalent small molecule degraders of cyclin-dependent kinase 7 (CDK7). European Journal of Medicinal Chemistry. 276: 116613
Liu HY, Li Z, Reindl T, et al. (2024) Broad-spectrum activity against mosquito-borne flaviviruses achieved by a targeted protein degradation mechanism. Nature Communications. 15: 5179
Li Z, Liu HY, He Z, et al. (2024) Discovery of Potent Degraders of the Dengue Virus Envelope Protein. Biorxiv : the Preprint Server For Biology
Arwood ML, Liu Y, Harkins SK, et al. (2023) New scaffolds for type II JAK2 inhibitors overcome the acquired G993A resistance mutation. Cell Chemical Biology
Lu W, Liu Y, Gao Y, et al. (2023) Development of a Covalent Inhibitor of c-Jun N-Terminal Protein Kinase (JNK) 2/3 with Selectivity over JNK1. Journal of Medicinal Chemistry. 66: 3356-3371
Fan M, Lu W, Che J, et al. (2022) Covalent disruptor of YAP-TEAD association suppresses defective hippo signaling. Elife. 11
Du G, Jiang J, Henning NJ, et al. (2022) Exploring the target scope of KEAP1 E3 ligase-based PROTACs. Cell Chemical Biology
Powell CE, Du G, Bushman JW, et al. (2021) Selective degradation-inducing probes for studying cereblon (CRBN) biology. Rsc Medicinal Chemistry. 12: 1381-1390
Jiang J, Jiang B, He Z, et al. (2020) Discovery of Covalent MKK4/7 Dual Inhibitor. Cell Chemical Biology
See more...